Zdrowie i gospodarka · 18/02/2014
FDA Classifies Neuropsychiatric EEG Assessment Aid into Class II with Special Controls
The FDA has classified the neuropsychiatric interpretive electroencephalograph assessment aid into Class II, requiring special controls to ensure the device's safety and effectiveness, following a review process.
Source: Federal Register — Food and Drug AdministrationOpen original release →